News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Procurement process open for the development of ATSTN National Training CentresProcurement process open for the development of ATSTN National Training CentresOctober newsletter: Driving the clinical adoption of cell and gene therapiesOctober newsletter: Driving the clinical adoption of cell and gene therapiesCelebrating the achievements of the Advanced Therapies Apprenticeship CommunityCelebrating the achievements of the Advanced Therapies Apprenticeship CommunityPress Release: CGT Catapult appoints two new Board membersPress Release: CGT Catapult appoints two new Board membersPress Release: Stevenage named High Potential Opportunity zone for Cell and Gene TherapyPress Release: Stevenage named High Potential Opportunity zone for Cell and Gene TherapyRegulatory News - September 2020Regulatory News - September 2020Press Release: CGT Catapult appoints Dr Nick Johnson as Chief Strategy and Impact OfficerPress Release: CGT Catapult appoints Dr Nick Johnson as Chief Strategy and Impact OfficerPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyAdvanced Therapy Treatment Centre network awarded £9.5m further investmentAdvanced Therapy Treatment Centre network awarded £9.5m further investmentJuly/August news: Large-scale manufacturing innovationJuly/August news: Large-scale manufacturing innovationRegulatory news - August 2020Regulatory news - August 2020Press release: Autolus Therapeutics to further expand operations at the CGT Catapult manufacturing centre to enable commercial manufacture of CAR-T cell therapiesPress release: Autolus Therapeutics to further expand operations at the CGT Catapult manufacturing centre to enable commercial manufacture of CAR-T cell therapies